MAZE THERAPEUTICS, INC. Income Taxes Paid
MAZE THERAPEUTICS, INC. (MAZE) reported Income Taxes Paid of $1.23 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-25
- MAZE THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2024-12-31 was $0.00.
- MAZE THERAPEUTICS, INC. income taxes paid, net for fiscal 2024 was $1.23M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.23M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.23M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |